Showing 1 - 10 of 23
Persistent link: https://www.econbiz.de/10001350924
Ex-ante regulations and ex-post liabilities for using a new technology will induce additional costs for adopters. The standard model is advanced by including irreversibility and uncertainty and taking into account transaction costs of negotiating possible cost reductions. The case analysed is...
Persistent link: https://www.econbiz.de/10003905106
Persistent link: https://www.econbiz.de/10009571566
Persistent link: https://www.econbiz.de/10009501349
Genetic insurance can deal with the negative effects of genetic testing on insurance coverage and income distribution when the insurer has access to information about test status. Hence, efficient testing is promoted. When information about prevention and test status is private, two types of...
Persistent link: https://www.econbiz.de/10011398910
The advantages and disadvantages of genetic modification of organisms in agriculture are reviewed. These relate to the environment, human health, socio-economic effects, population growth, and differential consequences for developed and developing countries. An overall evaluation requires that...
Persistent link: https://www.econbiz.de/10011316889
This paper connects the biofuels literature with genetic modifications literature by considering the potential of genetic modifications for increasing the efficiency of cellulosic biofuels production. This is done for one particular case through analyzing the effect of genetically modified corn...
Persistent link: https://www.econbiz.de/10010234035
A central theme in the international debate on genetic testing concerns the extent to which insurance companies should be allowed to use genetic information in their design of insurance contracts. We analyze this issue within a model with the following important feature: A person s well-being...
Persistent link: https://www.econbiz.de/10011402443
Genetic insurance can deal with the negative effects of genetic testing on insurance coverage and income distribution when the insurer has access to information about test status. Hence, efficient testing is promoted. When information about prevention and test status is private, two types of...
Persistent link: https://www.econbiz.de/10001606574
Persistent link: https://www.econbiz.de/10001782206